The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

Khunti, K.; Caputo, S.; Damci, T.; Dzida, G.; Ji, Q.; Kaiser, M.; Karnieli, E.; Liebl, A.; Ligthelm, R.; Nazeri, A.; Orozco-Beltran, D.; Pan, C.; Ross, S.; Svendsen, A.; Vora, J.; Yale, J.; Meneghini, L.

doi:10.1111/j.1463-1326.2012.01665.x

The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries

Khunti K., Caputo S., Damci T., Dzida G. J., Ji Q., Kaiser M., ...Daha Fazla

DIABETES OBESITY & METABOLISM, cilt.14, sa.12, ss.1129-1136, 2012 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 14 Sayı: 12
Basım Tarihi: 2012
Doi Numarası: 10.1111/j.1463-1326.2012.01665.x
Dergi Adı: DIABETES OBESITY & METABOLISM
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1129-1136
İstanbul Üniversitesi Adresli: Evet

Özet

Aims: Evaluate the safety and efficacy of once-daily insulin detemir initiated in routine clinical practice in patients with type 2 diabetes mellitus inadequately controlled with oral hypoglycaemic agents (OHAs).